-
Je něco špatně v tomto záznamu ?
In vitro antifungal susceptibility patterns of Trichophyton benhamiae complex isolates from diverse origin
F. Shamsizadeh, S. Ansari, A. Zarei Mahmoudabadi, V. Hubka, A. Čmoková, J. Guillot, A. Rafiei, K. Zomorodian, S. Nouripour-Sisakht, K. Diba, T. Mohammadi, H. Zarrinfar, A. Rezaei-Matehkolaei
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
Grantová podpora
NV17-31269A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Odkazy
PubMed
33864711
DOI
10.1111/myc.13287
Knihovny.cz E-zdroje
- MeSH
- antifungální látky farmakologie terapeutické užití MeSH
- Arthrodermataceae klasifikace účinky léků genetika izolace a purifikace MeSH
- lidé MeSH
- tinea farmakoterapie mikrobiologie MeSH
- zoonózy farmakoterapie mikrobiologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
- Írán MeSH
- Japonsko MeSH
- Spojené státy americké MeSH
BACKGROUND: Species from the Trichophyton benhamiae complex are mostly zoophilic dermatophytes which cause inflammatory dermatophytosis in animals and humans worldwide. OBJECTIVES: This study was purposed to (a) to identify 169 reference and clinical dermatophyte strains from the T benhamiae complex species by molecular method and adhering to the newest taxonomy in the complex (b) to evaluate the in vitro antifungal susceptibility profile of these strains against eight common and new antifungal agents that may be used for the treatment of dermatophytosis. METHODS: All isolates, mainly originated from Europe but also from Iran, Japan and USA, were subjected to ITS-rDNA sequencing. The in vitro antifungal susceptibility profiles of eight common and new antifungal drugs against the isolates were determined by CLSI M38-A2 protocol and according to microdilution method. RESULTS: Based on the ITS-rDNA sequencing, T benhamiae was the dominant species (n = 102), followed by T europaeum (n = 29), T erinacei (n = 23), T japonicum (n = 10), Trichophyton sp (n = 4) and T eriotrephon (n = 1). MIC ranges across all isolates were as follows: luliconazole: 0.0002-0.002 µg/ml, terbinafine: 0.008-0.125 µg/ml, efinaconazole: 0.008-0.125 µg/ml, ciclopirox olamine: 0.03-0.5 µg/ml, itraconazole: 0.06-2 µg/ml, griseofulvin: 0.25-4 µg/ml, amorolfine hydrochloride: 0.125-4 µg/ml and tavaborole: 1-16 µg/ml. CONCLUSION: Luliconazole, efinaconazole and terbinafine were the most potent antifungals against T benhamiae complex isolates, regardless of the geographic locations where strains were isolated. These data might help dermatologists to develop effective therapies for successful treatment of infections due to T benhamiae complex species.
Allergy Research Center Mashhad University of Medical Sciences Mashhad Iran
Department of Botany Faculty of Science Charles University Prague Czech Republic
Medicinal Plant Research Center Yasuj University of Medical Sciences Yasuj Iran
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003346
- 003
- CZ-PrNML
- 005
- 20220127150322.0
- 007
- ta
- 008
- 220113s2021 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/myc.13287 $2 doi
- 035 __
- $a (PubMed)33864711
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Shamsizadeh, Forough $u Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran $u Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
- 245 10
- $a In vitro antifungal susceptibility patterns of Trichophyton benhamiae complex isolates from diverse origin / $c F. Shamsizadeh, S. Ansari, A. Zarei Mahmoudabadi, V. Hubka, A. Čmoková, J. Guillot, A. Rafiei, K. Zomorodian, S. Nouripour-Sisakht, K. Diba, T. Mohammadi, H. Zarrinfar, A. Rezaei-Matehkolaei
- 520 9_
- $a BACKGROUND: Species from the Trichophyton benhamiae complex are mostly zoophilic dermatophytes which cause inflammatory dermatophytosis in animals and humans worldwide. OBJECTIVES: This study was purposed to (a) to identify 169 reference and clinical dermatophyte strains from the T benhamiae complex species by molecular method and adhering to the newest taxonomy in the complex (b) to evaluate the in vitro antifungal susceptibility profile of these strains against eight common and new antifungal agents that may be used for the treatment of dermatophytosis. METHODS: All isolates, mainly originated from Europe but also from Iran, Japan and USA, were subjected to ITS-rDNA sequencing. The in vitro antifungal susceptibility profiles of eight common and new antifungal drugs against the isolates were determined by CLSI M38-A2 protocol and according to microdilution method. RESULTS: Based on the ITS-rDNA sequencing, T benhamiae was the dominant species (n = 102), followed by T europaeum (n = 29), T erinacei (n = 23), T japonicum (n = 10), Trichophyton sp (n = 4) and T eriotrephon (n = 1). MIC ranges across all isolates were as follows: luliconazole: 0.0002-0.002 µg/ml, terbinafine: 0.008-0.125 µg/ml, efinaconazole: 0.008-0.125 µg/ml, ciclopirox olamine: 0.03-0.5 µg/ml, itraconazole: 0.06-2 µg/ml, griseofulvin: 0.25-4 µg/ml, amorolfine hydrochloride: 0.125-4 µg/ml and tavaborole: 1-16 µg/ml. CONCLUSION: Luliconazole, efinaconazole and terbinafine were the most potent antifungals against T benhamiae complex isolates, regardless of the geographic locations where strains were isolated. These data might help dermatologists to develop effective therapies for successful treatment of infections due to T benhamiae complex species.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antifungální látky $x farmakologie $x terapeutické užití $7 D000935
- 650 _2
- $a Arthrodermataceae $x klasifikace $x účinky léků $x genetika $x izolace a purifikace $7 D003883
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a tinea $x farmakoterapie $x mikrobiologie $7 D014005
- 650 _2
- $a zoonózy $x farmakoterapie $x mikrobiologie $7 D015047
- 651 _2
- $a Evropa $7 D005060
- 651 _2
- $a Írán $7 D007492
- 651 _2
- $a Japonsko $7 D007564
- 651 _2
- $a Spojené státy americké $7 D014481
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ansari, Saham $u Department of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- 700 1_
- $a Zarei Mahmoudabadi, Ali $u Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran $u Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
- 700 1_
- $a Hubka, Vít $u Department of Botany, Faculty of Science, Charles University, Prague, Czech Republic $u Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology, Czech Academy of Sciences, Vídeňská, Czech Republic
- 700 1_
- $a Čmoková, Adéla $u Department of Botany, Faculty of Science, Charles University, Prague, Czech Republic $u Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology, Czech Academy of Sciences, Vídeňská, Czech Republic
- 700 1_
- $a Guillot, Jacques $u Dynamic Research Group UPEC, EnvA, USC Anses, Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France
- 700 1_
- $a Rafiei, Abdollah $u Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran $u Department of Medical Parasitology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
- 700 1_
- $a Zomorodian, Kamiar $u Department of Medical Mycology and Parasitology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
- 700 1_
- $a Nouripour-Sisakht, Sadegh $u Medicinal Plant Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
- 700 1_
- $a Diba, Kambiz $u Department of Medical Mycology and Parasitology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran
- 700 1_
- $a Mohammadi, Tooba $u Department of Medical Mycology and Parasitology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
- 700 1_
- $a Zarrinfar, Hossein $u Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
- 700 1_
- $a Rezaei-Matehkolaei, Ali $u Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran $u Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
- 773 0_
- $w MED00010272 $t Mycoses $x 1439-0507 $g Roč. 64, č. 11 (2021), s. 1378-1386
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33864711 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127150318 $b ABA008
- 999 __
- $a ok $b bmc $g 1750961 $s 1154495
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 64 $c 11 $d 1378-1386 $e 20210425 $i 1439-0507 $m Mycoses $n Mycoses $x MED00010272
- GRA __
- $a NV17-31269A $p MZ0
- LZP __
- $a Pubmed-20220113